Country: Malta
Language: English
Source: Medicines Authority
NORTRIPTYLINE HYDROCHLORIDE
Pinewood Laboratories Ltd BALLYMACARBRY, CLONMEL, CO. TIPPERARY, Ireland
N06AA10
NORTRIPTYLINE HYDROCHLORIDE 10 mg
FILM-COATED TABLET
NORTRIPTYLINE HYDROCHLORIDE 10 mg
POM
PSYCHOANALEPTICS
Licence number in the source country: NOT APPLICAPABLE
Authorised
2020-11-11
Page 1 of 8 PACKAGE LEAFLET: INFORMATION FOR THE PATIENT NORTRIPTYLINE 10MG FILM-COATED TABLETS NORTRIPTYLINE 25MG FILM-COATED TABLETS NORTRIPTYLINE 50MG FILM-COATED TABLETS READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or pharmacist. - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. - If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET 1. What Nortriptyline is and what it is used for 2. What you need to know before you take Nortriptyline 3. How to take Nortriptyline 4. Possible side effects 5. How to store Nortriptyline 6. Contents of the pack and other information 1. WHAT NORTRIPTYLINE IS AND WHAT IT IS USED FOR Nortriptyline contains the active ingredient nortriptyline hydrochloride, which is a tricyclic antidepressant. Nortriptyline is used to treat major depression in adults. 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE NORTRIPTYLINE _ _ DO NOT TAKE NORTRIPTYLINE IF: • you are ALLERGIC (hypersensitive) to nortriptyline or any of the other ingredients of Nortriptyline (see list of ingredients in Section 6). An allergic reaction may include rash, itching, difficulty breathing or swelling of the face, lips, throat or tongue • you have had a RECENT HEART ATTACK or heartbeat disorder, heart block or coronary artery disease • you are taking, or have stopped taking within the last 14 days, a monoamine oxidase inhibitor (e.g. PHENELZINE, ISOCARBOXAZID OR TRANYLCYPROMINE ). If you are taking MOCLOBEMIDE you must stop this at least 24 hours before starting nortriptyline • you have to stop treatment with Nortriptyline and wait for 14 days before you start treatment with a monoamine oxidase inhibitor • have ever had pr Read the complete document
Page 1 of 13 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Nortriptyline 10mg film-coated tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each film-coated tablet contains nortriptyline hydrochloride equivalent to 10 mg nortriptyline. Excipients with known effect Each tablet contains 48.7 mg of lactose. For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Film-coated tablet. The score line is only to facilitate breaking for ease of swallowing and not to divide into equal doses. White to off white, round, biconvex film coated tablet debossed with ‘NT’ on one side and ‘10’on the other side. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Nortriptyline is indicated for the treatment of Major Depressive Episodes in adults. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology ADULTS The usual adult dose is 25mg three or four times daily. Dosage should begin at a low level e.g. 10mg three or four times daily and be increased as required. Alternatively, the total daily dose may be given once a day, usually given at night. When doses above 100mg daily are administered, plasma levels of nortriptyline should be monitored and maintained in the optimum range of 50 to 150ng/ml. Doses above 150mg per day are not recommended. Lower than usual dosages are recommended for elderly patients. Lower dosages are also recommended for outpatients than for hospitalised patients who will be under close supervision. The physician should initiate dosage at a low level and increase it gradually, noting carefully the clinical response and any evidence of intolerance. Following remission, maintenance medication may be required for a longer period of time at the lowest dose that will maintain remission. Page 2 of 13 If a patient develops minor side-effects, the dosage should be reduced. The drug should be discontinued promptly if adverse effects of a serious nature or allergic manifestations occur. ELDERLY 30 to 50 mg/day in divided doses. Dosage should begin at a low level (10 – 20 mg da Read the complete document